AGX813

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 615

suitable for ELISA

• Synonym(e): 2019-nCoV, COVID-19
• UNSPSC-Code: 51201600
• NACRES: NA.26

Eigenschaften

• Rekombinant: expressed in E. coli
• Qualitätsniveau: 100
• Form: liquid
• Mol-Gew.: ≤48 kDa
• Lagerbedingungen: avoid repeated freeze/thaw cycles
• Methode(n): ELISA: suitable
• Versandbedingung: dry ice

Beschreibung

Allgemeine Beschreibung

SARS2-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E. coli, Cat. No. AGX813 is for use in ELISA.

Zielbeschreibung

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Physikalische Form

Purified protein in 25mM Tris-HCl without preservatives, pH 8.0.

Rekonstituierung

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Lagerung und Haltbarkeit

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Haftungsausschluss

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Sicherheitshinweise

• Lagerklassenschlüssel: 12 - Non Combustible Liquids
• WGK: nwg
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable